The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Distinct differences in genomic profile of gastric and gastroesophageal junction adenocarcinoma.
 
Masaya Nakauchi
No Relationships to Disclose
 
Henry S. Walch
No Relationships to Disclose
 
Walid Khaled Chatila
No Relationships to Disclose
 
Thinh Tran
No Relationships to Disclose
 
Elvira Lise Vos
No Relationships to Disclose
 
Smita Sihag
No Relationships to Disclose
 
Laura H. Tang
No Relationships to Disclose
 
Daniel G. Coit
No Relationships to Disclose
 
Zsofia Kinga Stadler
Consulting or Advisory Role - Adverum (I); Allergan (I); Genentech/Roche (I); Gyroscope (I); Neurogene (I); Novartis (I); Optos (I); Regeneron (I); Regenxbio (I)
 
Yelena Y. Janjigian
Stock and Other Ownership Interests - Rgenix
Consulting or Advisory Role - AstraZeneca; Basilea Pharmaceutical; Bayer; Bristol-Myers Squibb; Daiichi Sankyo; Imugene; Lilly; Merck; Merck Serono; Michael J. Hennessy Associates; Paradigm; Pfizer; Rgenix; Seagen; Zymeworks
Research Funding - Bayer (Inst); Bristol-Myers Squibb (Inst); Cycle for Survival (Inst); Department of Defense (Inst); Fred's Team (Inst); Genentech/Roche (Inst); Lilly (Inst); Merck (Inst); NCI (Inst); Rgenix (Inst)
Other Relationship - Axis Medical Education; Clinical Care Options; Research to Practice
 
Steven Brad Maron
Stock and Other Ownership Interests - Calithera Biosciences
Consulting or Advisory Role - Basilea; Bicara Therapeutics; Daichi Sankyo; Natera
Research Funding - Guardant Health (Inst); Roche/Genentech (Inst)
Travel, Accommodations, Expenses - Bayer; Merck
 
Geoffrey Yuyat Ku
Consulting or Advisory Role - Apexigen; Bristol-Myers Squibb; I-Mab; Merck Sharp & Dohme; Pieris Pharmaceuticals
Research Funding - Arog (Inst); Bristol-Myers Squibb (Inst); Daiichi Sankyo (Inst); MedImmune (Inst); Merck (Inst); Oncolys BioPharma (Inst); Pieris Pharmaceuticals (Inst); Zymeworks (Inst)
Travel, Accommodations, Expenses - Aduro Biotech; AstraZeneca/MedImmune; Bristol-Myers Squibb; Merck Sharp & Dohme; Pieris Pharmaceuticals
 
David H. Ilson
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bayer; Bristol-Myers Squibb; IQvia; Lilly/ImClone; Macrogenics; Merck; Pieris Pharmaceuticals; Roche/Genentech; Taiho Pharmaceutical
 
David B. Solit
Stock and Other Ownership Interests - Fore Biotherapeutics; Loxo; Scorpion Therapeutics; Vividion Therapeutics
Consulting or Advisory Role - BridgeBio Pharma; Lilly; Pfizer; QED Therapeutics; Scorpion Therapeutics; Syros Pharmaceuticals; Vividion Therapeutics
 
Nikolaus Schultz
No Relationships to Disclose
 
Daniela Molena
Consulting or Advisory Role - Boston Scientific; Intuitive Surgical; Johnson & Johnson; Urogen pharma
 
Vivian E. Strong
No Relationships to Disclose